4
Changes in Ownership
Werewolf Therapeutics, Inc. Filed Acc 0001134657-26-000001
Director sold 78,377 shares at an average $0.62 ($48,431)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| EVNIN LUKE Director | 2025-12-30 | Sale 10b5-1 | −34,847 | $0.61 | $21,257 | 2,515,827 | I: show line 1 in the form |
| EVNIN LUKE Director | 2025-12-31 | Sale 10b5-1 | −24,962 | $0.62 | $15,476 | 2,490,865 | I: show line 2 in the form |
| EVNIN LUKE Director | 2026-01-02 | Sale 10b5-1 | −18,568 | $0.63 | $11,698 | 2,472,297 | I: show line 3 in the form |
| Open-market sales · 78,377 sh · avg $0.62 · $48,431 | |||||||
Loading xslF345X05/form4-01022026_100128.xml…